Nothing Special   »   [go: up one dir, main page]

LV10235B - New esters, method of preparation thereof, pharmaceutical composition and method of treatment - Google Patents

New esters, method of preparation thereof, pharmaceutical composition and method of treatment

Info

Publication number
LV10235B
LV10235B LVP-93-514A LV930514A LV10235B LV 10235 B LV10235 B LV 10235B LV 930514 A LV930514 A LV 930514A LV 10235 B LV10235 B LV 10235B
Authority
LV
Latvia
Prior art keywords
preparation
treatment
pharmaceutical composition
new esters
carbon atoms
Prior art date
Application number
LVP-93-514A
Other languages
English (en)
Other versions
LV10235A (lv
Inventor
Bertil Valdemar Hansen
Per-Olov Gunnar Gunnarsson
Henri Rene Mollberg
Sven-Ake Johansson
Original Assignee
Kabi Pharmacia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kabi Pharmacia Ab filed Critical Kabi Pharmacia Ab
Publication of LV10235A publication Critical patent/LV10235A/xx
Publication of LV10235B publication Critical patent/LV10235B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/40—Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of six-membered aromatic rings
    • C07C271/42—Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of six-membered aromatic rings with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/46—Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of six-membered aromatic rings with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by halogen atoms or by nitro or nitroso groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0072—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the A ring of the steroid being aromatic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Cephalosporin Compounds (AREA)
LVP-93-514A 1988-06-28 1993-06-08 New esters, method of preparation thereof, pharmaceutical composition and method of treatment LV10235B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8802402A SE8802402D0 (sv) 1988-06-28 1988-06-28 Novel esters

Publications (2)

Publication Number Publication Date
LV10235A LV10235A (lv) 1994-10-20
LV10235B true LV10235B (en) 1995-04-20

Family

ID=20372746

Family Applications (1)

Application Number Title Priority Date Filing Date
LVP-93-514A LV10235B (en) 1988-06-28 1993-06-08 New esters, method of preparation thereof, pharmaceutical composition and method of treatment

Country Status (25)

Country Link
US (1) US5036062A (xx)
EP (1) EP0351561B1 (xx)
JP (1) JP2563587B2 (xx)
KR (1) KR910000607A (xx)
CN (1) CN1031060C (xx)
AT (1) ATE96446T1 (xx)
CA (1) CA1317587C (xx)
DD (1) DD284026A5 (xx)
DE (1) DE68910211T2 (xx)
DK (1) DK318989A (xx)
ES (1) ES2059626T3 (xx)
FI (1) FI92707C (xx)
HU (1) HU203766B (xx)
IE (1) IE62462B1 (xx)
IL (1) IL90724A0 (xx)
LT (1) LT3548B (xx)
LV (1) LV10235B (xx)
MD (1) MD940402A (xx)
NO (1) NO172939C (xx)
NZ (1) NZ229649A (xx)
PH (1) PH30437A (xx)
PT (1) PT90986B (xx)
RU (1) RU2036929C1 (xx)
SE (1) SE8802402D0 (xx)
ZA (1) ZA894716B (xx)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5209926A (en) * 1990-06-12 1993-05-11 Insite Vision Incorporated Aminosteroids for ophthalmic use
US5256408A (en) * 1990-06-12 1993-10-26 Insite Vision Incorporated Aminosteroids for ophthalmic use
US5124154A (en) * 1990-06-12 1992-06-23 Insite Vision Incorporated Aminosteroids for ophthalmic use
US5252319A (en) * 1990-06-12 1993-10-12 Insite Vision Incorporated Aminosteroids for ophthalmic use
JP2520074B2 (ja) * 1992-06-11 1996-07-31 呉羽化学工業株式会社 新規なエストラジオ―ル誘導体−クロラムブチル結合体、その製造方法、及び医薬製剤
JPH07101977A (ja) * 1993-10-05 1995-04-18 Kureha Chem Ind Co Ltd ホルモン作用を軽減した新規なエストラジオール誘導体及びその増殖因子阻害剤
FR2717690B1 (fr) * 1994-03-24 1996-04-26 Roussel Uclaf Application de stéroïdes aromatiques 3 substitués par un aminoalcoxy substitué à l'obtention d'un médicament pour contrôler la stérilité, notamment masculine.
GB9419153D0 (en) * 1994-09-22 1994-11-09 Erba Carlo Spa Estramustine formulations with improved pharmaceutical properties
US20030108764A1 (en) * 2001-12-04 2003-06-12 Neill John Thomas Method for improving bonding of circuit board substrates to metal surfaces and the articles formed thereby
CN101463295B (zh) * 2008-11-28 2011-08-17 江苏海迅实业集团股份有限公司 半导体工业用清洗剂
CN105636592A (zh) 2013-07-11 2016-06-01 伊万斯彻有限公司 形成前药的化合物
MX2020003470A (es) 2017-10-19 2020-10-01 Evestra Inc Anticonceptivos de profarmacos de progestina de accion mas prolongada.
CN112979744B (zh) * 2021-02-18 2022-02-15 齐齐哈尔医学院 具有抗肿瘤活性的薯蓣皂苷元拼合氮芥衍生物及其制备方法和用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1126386B (de) * 1959-11-14 1962-03-29 Hoechst Ag Verfahren zur Herstellung von Steroid-21-aminosaeureestern
US3299104A (en) * 1963-04-09 1967-01-17 Leo Ab Certain steroid nu-bis-(haloethyl)-carbamates
US4443440A (en) * 1982-08-30 1984-04-17 The Upjohn Company Amine containing ester prodrugs of corticosteroids
US4615835A (en) * 1983-11-17 1986-10-07 Stiftung Deutsches Krebsforschungs Zentrum Steroid esters of N-(2-halogenethyl)-N-nitroso-carbamoylamino and acids and peptides therefore, as well as method for preparing them
JPS617292A (ja) * 1984-06-20 1986-01-13 Japan Atom Energy Res Inst 制癌剤を結合させたエストラサイト系化合物を製造する方法

Also Published As

Publication number Publication date
EP0351561B1 (en) 1993-10-27
ES2059626T3 (es) 1994-11-16
CA1317587C (en) 1993-05-11
FI893130A (fi) 1989-12-29
NZ229649A (en) 1991-12-23
FI893130A0 (fi) 1989-06-27
AU607621B2 (en) 1991-03-07
DE68910211T2 (de) 1994-05-11
PT90986A (pt) 1989-12-29
JP2563587B2 (ja) 1996-12-11
KR910000607A (ko) 1991-01-29
AU3668289A (en) 1990-01-04
PT90986B (pt) 1994-11-30
LV10235A (lv) 1994-10-20
JPH0253795A (ja) 1990-02-22
NO892672L (no) 1989-12-29
IL90724A0 (en) 1990-01-18
NO172939C (no) 1993-09-29
DK318989A (da) 1989-12-29
LTIP603A (en) 1995-01-31
NO892672D0 (no) 1989-06-27
FI92707C (fi) 1994-12-27
ZA894716B (en) 1990-03-28
DD284026A5 (de) 1990-10-31
SE8802402D0 (sv) 1988-06-28
FI92707B (fi) 1994-09-15
ATE96446T1 (de) 1993-11-15
US5036062A (en) 1991-07-30
HUT52521A (en) 1990-07-28
IE62462B1 (en) 1995-02-08
IE891908L (en) 1989-12-28
CN1045792A (zh) 1990-10-03
DE68910211D1 (de) 1993-12-02
EP0351561A1 (en) 1990-01-24
RU2036929C1 (ru) 1995-06-09
LT3548B (en) 1995-11-27
MD940402A (ro) 1996-01-31
DK318989D0 (da) 1989-06-27
CN1031060C (zh) 1996-02-21
NO172939B (no) 1993-06-21
PH30437A (en) 1997-05-09
HU203766B (en) 1991-09-30

Similar Documents

Publication Publication Date Title
ES8403858A1 (es) Procedimiento para la preparacion de dipeptidos carboxialquilicos.
EP0150937A3 (en) Dihydropyridazinones
HUT52059A (en) Process for producing pharmaceutical compositions and new quinoline derivatives as a group of active components
HUT59377A (en) Process for producing drugs containing new aromatic rings
MY100095A (en) 2-oxo-imidazolidine compounds, a process for preparing the same and a pharmaceutical composition.
LV10235B (en) New esters, method of preparation thereof, pharmaceutical composition and method of treatment
GR3020682T3 (en) Use of dioxabicyclo [3.3.0]octane derivatives for the manufacture of a medicament for inhibiting the metabolism of cholesterol.
PH24176A (en) New bicyclic compounds,process for preparation thereof and pharmaceutical composition comprising the same
ZA892695B (en) 2-alkyl-3-benzoylbenzofurans and pharmaceutical compositions containing them
ES8706610A1 (es) Proceso para preparar un derivado de aminoalcohol.
ES8604960A1 (es) Procedimiento para preparar derivados de 1,6-naftiridina
EP0123146A3 (en) Compounds with antiinflammatory activity, process for preparation thereof and pharmaceutical compositions therefrom
HUT47923A (en) Process for production of new derivatives of naphtotiazephin and medical compositions containing these substances
HUT45059A (en) Process for producing abeoergoline derivatives
AU586089B2 (en) Phosphodiesterace type 111 inhibitors having a thiadiazinone ring as part of a tricyclic structure
HUT51895A (en) Process for production of antiflammation medical compositions containing derivatives of imidasole